Moderna’s new mRNA vaccine could improve flu protection, but the holy grail is a universal vaccine.

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker

The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine to counter any future flu pandemic.

Moderna forecasts hundreds of millions of dollars in windfall profits